MD3001 - Tissue Injury and Neoplasia

Credit points:	03
Year:	2005
Student Contribution Band:	Band 3
Administered by:

This subject provides students with an understanding of the mechanisms surrounding tissue injury and the relationship between tissue injury, organ systems and the disease process. this knowledge will provide the foundation for the study of the control of cell growth and differentiation and the mechanisms involved in neoplasia. Students will gain an understanding of oncogenes, the causes of cancer and tumour immunology, growth, invasion and metastasis.

Learning Outcomes

• ability to communicate with empathy with patients and their families and effectively with other professionals and peers;
• ability to observe and describe gross and histopathological lesions as a prerequisite to the development of clinical skills;
• ability to take a medical history relevant to cancer;
• awareness of factors that can prevent cancer;
• be knowledgeable regarding the changes which occur in tissues during health and disease (particularly carcinogenesis) and the effects of therapies;
• obtain sufficient background in microscopy, histology/pathohistology, staining techniques, assessment of plasma enzyme/electrolytes, immuhistochemistry, assessment of tumour markers and flow cytometry;
• understand the cellular processes involved in tissue injury and the gross histological and pathohistological morphology of diseased tissues as related to tissue injury and neoplasia.

Prerequisites:

All level 1 and level 2 subjects in MBBS program

Availabilities
, , Study Period 0
Census Date 06-May-2005
Coordinator:	tvpms
Lecturers:	jc122670, Professor Richard Hays, tvpms.
Contact hours:	13 hours
Assessment:	(80%); (20%).
Special Assessment Requirements:	This subject is assessed within an integrated assessment program for all Year 3 subjects. The assessment as detailed below, is the integrated assessment schedule for all Level 3 subjects. Students must participate in all formative assessment tasks to be eligible to sit the summative assessments. Attendance at clinical placements is mandatory and completion to a satisfactory level is required.

Note: Minor variations might occur due to the continuous Subject quality improvement process, and in case of minor variation(s) in assessment details, the Subject Outline represents the latest official information.